Related Experiment Video
Updated: May 1, 2026

A Mouse Model to Assess Innate Immune Response to Staphylococcus aureus Infection
Published on: February 28, 2019
Targeting Staphylococcus aureus α-toxin as a novel approach to reduce severity of recurrent skin and soft-tissue
Georgia R Sampedro1, Andrea C DeDent1, Russell E N Becker2
1Department of Pediatrics Department of Microbiology.
Insights
Targeting Staphylococcus aureus alpha-toxin during primary skin infections can reduce recurrent disease severity. Neutralizing this toxin early offers a new therapeutic strategy for both initial and subsequent infections.
Area of Science:
- Microbiology
- Immunology
- Infectious Diseases
Background:
- Staphylococcus aureus is a common cause of recurrent skin and soft-tissue infections (SSTIs).
- Elevated antibodies against S. aureus alpha-toxin correlate with lower rates of recurrent SSTIs in children.
- Alpha-toxin plays a role in the pathogenesis of S. aureus infections.
Purpose of the Study:
- To investigate the role of alpha-toxin in recurrent SSTIs using a novel animal model.
- To evaluate the therapeutic potential of antagonizing alpha-toxin during primary infection to prevent recurrent disease.
Main Methods:
- Development and utilization of a novel mouse model for recurrent S. aureus SSTI.
- Assessment of alpha-toxin expression during primary infection and its impact on recurrent disease severity.
- Intervention strategies included a dominant-negative alpha-toxin mutant and a small molecule inhibitor of ADAM10 (alpha-toxin receptor).
Main Results:
- Alpha-toxin expression during primary infection exacerbated the severity of recurrent SSTI.
- Antagonizing alpha-toxin activity during primary infection significantly reduced the severity of reinfection abscesses.
- Early neutralization of alpha-toxin demonstrated a protective effect against recurrent disease.
Conclusions:
- Alpha-toxin is a critical factor in the pathogenesis of recurrent S. aureus SSTIs.
- Targeting alpha-toxin, either through direct antagonism or inhibition of its receptor (ADAM10), represents a promising therapeutic approach.
- Early intervention to neutralize alpha-toxin activity could mitigate both primary and recurrent S. aureus infections.
Abstract:
Staphyococcus aureus frequently causes recurrent skin and soft-tissue infection (SSTI). In the pediatric population, elevated serum antibody targeting S. aureus α-toxin is correlated with a reduced incidence of recurrent SSTI. Using a novel model of recurrent SSTI, we demonstrated that expression of α-toxin during primary infection increases the severity of recurrent disease. Antagonism of α-toxin by either a dominant-negative toxin mutant or a small molecule inhibitor of the toxin receptor ADAM10 during primary infection reduces reinfection abscess severity. Early neutralization of α-toxin activity during S. aureus SSTI therefore offers a new therapeutic strategy to mitigate primary and recurrent disease.
More Related Videos
Related Concept Videos
Staphylococcal Skin Infections
Clinical Significance of Antibiotic Resistance
Bacterial Toxins
Mechanism of Antibiotic Resistance in MRSA
Gene Regulation in Microbial Communities: Quorum Sensing
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

